Fairvalue-Calculator Fairvalue-Calculator
EN DE

DocCheck AG (AJ91) Fair Value & Analysis

Healthcare · DE · Market cap €66.0M

Price€11.70
Fair Value€18.54
Upside+58.5%
Quality95/100
Evidence: High Range €11.79 – €27.57

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DocCheck AG (AJ91) currently trades at €11.70, while our model-based Fair Value estimate is €18.54 — implying the stock looks roughly 58.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

DocCheck AG offers community, agency, and e-commerce services for the healthcare sector in Europe. The company develops and implements communication strategies for media on healthcare and business-to-business sectors; sells medical supplies and medical technology primarily via mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is DocCheck AG (AJ91) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €18.54 versus a price of €11.70 — about +58% (undervalued). Model-based estimate, not financial advice.
What is the fair value of AJ91?
Our 21-model fair value for DocCheck AG is €18.54 (as of Jun 24, 2026), built from audited fundamentals. The current price is €11.70.
What is the quality score of AJ91?
DocCheck AG has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.